QC Ware and IonQ Demonstrate High-Precision Hybrid Quantum Workflow for Drug Discovery

QC Ware and IonQ demonstrated a high-precision hybrid quantum-classical workflow for drug discovery, accurately modeling enzyme active sites with error within 4% of classical benchmarks, surpassing chemical accuracy thresholds. The workflow leverages QC Ware’s Promethium platform with IonQ Forte quantum hardware via Amazon Braket, accelerating computations up to 20 times faster than conventional methods.

This Wire brief sits within Fusion42's coverage of Quantum Computing and Drug Discovery, and 3 sources have reported it between 1 Sep 2026 and 2 Sep 2026.